Skip to main content
SpringerLink
Log in

Adalimumab/anakinra/tocilizumab

Treatment failure and allergic reaction: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Crisafulli F, et al. Retention rate of il-1 inhibitors in patients with schnitzler's syndrome. Annals of the Rheumatic Diseases 80 (Suppl.): 51-52 (plus oral presentation) abstr. OP0093, 2021. Available from: URL: http://doi.org/10.1136/annrheumdis-2021-eular.3071

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/anakinra/tocilizumab. Reactions Weekly 1870, 18 (2021). https://doi.org/10.1007/s40278-021-01228-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-01228-0

Search

Navigation